Synthetic Biology

NutraCast: Why Ayana Bio CEO Frank Jaksch is betting on synbio

02-Dec-2022 By Danielle Masterson

Synthetic biology technologies make it possible to create just about anything sustainably – including plants and fungal bioactives. Synbio has become a disruptive force that a growing number of companies are leaning into, including plant cell tech startup...

NutraCast: Utilizing synthetic biology to preserve medicinal plants

28-Oct-2022 By Danielle Masterson

Some of our most important natural resources are being over-harvested and over-taxed. As a result, DoubleRainbow Biosciences launched Landkind to create sustainable versions of the world's most endangered ingredients.

Frank Jaksch joins Ayana Bio as CEO: ‘I’m really excited about being back in the exploration mode’

24-Aug-2022 By Stephen Daniells

Plant cell technology company and Ginkgo Bioworks spin off Ayana Bio has appointed ChromaDex founder and former CEO Frank Jaksch as its new CEO.

New research could lead to engineered beneficial bacteria, gut microbiome manipulation

23-Nov-2020 By Danielle Masterson

Rearchers have uncovered information gleaned from virus discovery that could be used to control the composition of the gut microbiome.

The role of synthetic biology in sustainably sourcing ingredients

17-Sep-2020 By Danielle Masterson

Technology is key in sustainability, identity and security. At the forefront is synthetic biology, with some pointing to the tool as the answer to solving these pressing and emerging needs.

Guest article

ONHA’s view: Don’t let strong sales in 2019 obscure important issues

20-Dec-2019 By Karen Howard, CEO and Executive Director of Organic & Natural Health Association

Successful evaluation of the progress or travails of 2019 requires more than measuring growth in dietary supplements sales, which by that measure alone indicates we had a banner year.